Jericho Capital Asset Management L.P.

Q2 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
22
Total value ($000)
$2,556,361
Net value change ($000)
+147,736 (6.1%)
New positions
7
Sold out positions
13
Turnover %
86.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/15/2023 Next filing: 11/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AIY 379,143 NEW
TMUS 333,657 NEW
CDNS 177,615 244.5%
LYV 125,185 NEW
NVDA 81,011 95.6%
MSFT 80,708 NEW
DKNG 77,264 130.8%
PLTR 76,650 NEW
DLR 37,865 NEW
LYFT 34,942 NEW
Top Reduces (Value $000, Stocks/ETFs)
BABA -371,217 -100.0%
GOOGL -175,563 -100.0%
ONON -85,572 -100.0%
OKTA -80,548 -100.0%
AYXGBX -79,678 -100.0%
CLVT -79,096 -100.0%
XYZ -62,677 -100.0%
NFLX -59,846 -24.8%
Revance Therapeutics, Inc. -46,340 -100.0%
META -46,006 -21.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None